Omada Health
OMDA | NASDAQ
$18.21
-$0.52 (-2.78%)
Nov 2, 2026, 1:41 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
Revenue | 260.21M | 169.8M | 122.78M | 89.19M |
Cost of Revenue | 89.27M | 66.92M | 52.81M | 46.39M |
Gross Profit | 170.94M | 102.88M | 69.97M | 42.79M |
Operating Income | -11.97M | -43.65M | -66M | -72.35M |
Interest Income | 5.31M | 805K | 5.78M | 2.2M |
Pretax Income | -12.78M | -47.14M | -67.51M | -72.52M |
Net Income | -12.78M | -47.14M | -67.51M | -72.52M |
Selling & General & Admin | 142.23M | 110.61M | 102.23M | 88.97M |
Research & Development | 40.68M | 35.92M | 33.74M | 26.17M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 182.91M | 146.53M | 135.97M | 115.14M |
Interest Expense | 2.53M | 4.51M | 4.71M | 4.2M |
Selling & Marketing Expenses | 90.04M | 68.05M | 66.25M | 58.48M |
Cost & Expenses | 272.18M | 213.45M | 188.78M | 161.54M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 58.43M | 55.74M | 55.74M | 55.74M |
Shares Outstanding (Diluted) | 58.43M | 55.74M | 55.74M | 55.74M |
EPS (Basic) | -0.22 | -0.85 | -1.21 | -1.30 |
EPS (Diluted) | -0.22 | -0.85 | -1.21 | -1.30 |
EBITDA | -4.75M | -37.83M | -58.36M | -63.99M |
EBIT | -10.24M | -42.63M | -62.81M | -68.32M |
Depreciation & Amortization | 5.49M | 4.8M | 4.45M | 4.33M |
Add to Watchlist
Select watchlists to add or remove OMDA